Artículos de revistas
Timely Implementation Of Interventions To Reduce Vertical Hiv Transmission: A Successful Experience In Brazil [implementação Oportuna De Intervenções Para Reduzir A Transmissão Vertical Do Hiv: Uma Experiência Brasileira Bem-sucedida]
Registro en:
Revista Panamericana De Salud Publica/pan American Journal Of Public Health. , v. 21, n. 6, p. 357 - 364, 2007.
10204989
2-s2.0-35448984943
Autor
Amaral E.
Assis-Gomes F.
Milanez H.
Cecatti J.G.
Vilela M.M.
Pinto e Silva J.L.
Institución
Resumen
Objective. To describe the impact, at the public maternity facility of a university hospital in Brazil, of the rapid implementation of new guidelines recommended by national consensus panels concerning the prevention of vertical HIV transmission. Method. We performed a retrospective study of deliveries by HIV-infected women at the public maternity facility of a university hospital in the city of Campinas, São Paulo, Brazil, from 1990 through 2000. The guidelines utilized at the facility during this period were: (1) from 1990 through 1994, contraindication to breast-feeding and no use of antiretroviral drugs; (2) 1995 and 1996, use of zidovudine (AZT) by the pregnant woman and the newborn; (3) 1997 and 1998, use of AZT according to the ACTG 076 protocol; and (4) 1999 and 2000, multiple antiretroviral agents and elective cesarean delivery. All the antiretroviral drugs were provided for free by Brazil's public health care system. The vertical transmission rate was calculated for each of the four stages, and the risk ratio for congenital transmission was calculated for each stage and for each prophylactic intervention separately (breast-feeding, type of antiretroviral drug, type of delivery). Results. We studied 197 deliveries at the public maternity facility over that 1990-2000 period. Over the four stages, the rate of vertical transmission decreased: it was 32.3% in the first stage, 25.7% in the second, 2.2% in the third, and 2.9% in the fourth. The most pronounced decrease, observed from the second to the third stage, occurred after introduction of the full ACTG 076 regimen. The use of combined antiretroviral agents increased from 0% in the first stage to 46.4% in the fourth stage. There were no cases of vertical transmission in pregnant women treated with multiple drugs. The risk of vertical HIV transmission was 5 times as great with breast-feeding vs. no breast-feeding (risk ratio = 5.06), 5 times as great with no antiretroviral therapy vs. the full ACTG 076 regimen (risk ratio = 5.29), and 4 times as great with forceps delivery vs. elective cesarean delivery (risk ratio = 4.13). Conclusion. The timely adoption of up-to-date interventions recommended by national consensus panels, along with the free provision of antiretroviral drugs, was effective in reducing congenital HIV transmission in this public maternity facility. The interaction between the university hospital health service and the pubuc health service reduced the time needed for implementation of proven, effective interventions, and this experience could serve as an example for other maternal and perinatal health situations. 21 6 357 364 (1999) The World Health report 1999 - making a difference, , World Health Organization, Genebra: WHO; (1998) HIV in pregnancy: A review, , World Health Organization, Genebra: WHO; Brasil, Ministério da Saúde. Coordenação Nacional de DST/AIDS. Bol Epidemiol (2000) AIDS, 18 (1), pp. 3-23 Amaral E, Faúndes A, Gonçalves NS, Pelegrino Junior J, de Souza CA, Pinto e Silva JL. Prevalence of HIV and Treponema pallidum infections in pregnant women in Campinas and their association with socio-demographic factors. Sao Paulo Med J. 1996;114:1108-16Szwarcwald CL. Relatório: primeiros resultados do estudo sentinela parturiente. Disponível em: http://www.aids.gov.br/final/biblioteca/ relatorios_07_2005 /relatorio_2004_sentinela_parturiente.pdf#search= %22estudo%20sentinela%20Brasil%20HIV%22. Acessado em junho de 2007The World Health Report (1998) Life in the 21st century: A vision for all, , World Health Organization, Genebra: WHO; Connor, E.M., Sperling, R.S., Gelber, R., Kiselev, P., Scott, G., O'Sullivan, M.J., Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group (1994) New Engl J Med, 331 (18), pp. 1173-1180 Matheson, P.B., Abrams, E.J., Thomas, P.A., Hernán, M.A., Thea, D.M., Lambert, G., Efficacy of antenatal zidovudine in reducing perinatal transmission of human immunodeficiency virus type 1. The New York City Perinatal HIV Transmission Collaborative Study Group (1995) J Infect Dis, 172 (2), pp. 353-358 Mayaux, M.J., Teglas, J.P., Mandelbrot, L., Berrebi, A., Gallais, H., Matheron, S., Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus - 1 transmission in France (1997) J Pediatr, 131 (6), pp. 857-862 Lindegren, M.L., Byers, R.H., Thomas, P., Davis, S.F., Caldwell, B., Rogers, M., Trends in perinatal transmission of HIV/AIDS in the United States (1999) JAMA, 282 (6), pp. 531-538 Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy (2005) Clin Infect Dis, 40 (3), pp. 458-465. , European Collaborative Study Tess, B.H., Rodrigues, L.C., Newell, M.L., Dunn, D.T., Lago, T.D., Breastfeeding, genetic, obstetric and other risk factors associated with mother-to-child transmission of HIV-1 in Sao Paulo State, Brazil. Sao Paulo Collaborative Study for Vertical Transmission of HIV-1 (1998) AIDS, 12 (5), pp. 513-520 Brasil, Ministério da Saúde. Coordenação Nacional de DST/AIDS. Vigilância de HIV em gestantes e crianças expostas. Bol Epidemiol (2000) AIDS, 18, p. 2 Brasil, Ministério da Saúde. Coordenação Nacional de DST/AIDS. Uso do teste rápido para indicação de profilaxia da transmissão vertical do HIV em gestantes. Bol Epidemiol (1999) AIDS, 12, p. 1 Brasil, Ministério da Saúde. Coordenação Nacional de DST e AIDS. Recomendações para profilaxia da transmissão vertical do HIV e terapia anti-retroviral em gestantes. Brasília: Ministério da Saúde 2003De Brito, A.M., De Sousa, J.L., Luna, C.F., Dourado, I., Trends in maternal-infant transmission of AIDS after antiretroviral therapy in Brazil (2006) Rev Saude Publica, 40 (SUPPL.), pp. 18-22 da Silveira Rossi, A., Fonsechi-Carvasan, G.A., Makuch, M.Y., Amaral, E., Bahamondes, L., Factors associated with reproductive options in HIV-infected women (2005) Contraception, 71 (1), pp. 45-50 Paiva, V., Filipe, E.V., Santos, N., Lima, T.N., Segurado, A., The right to love: The desire for parenthood among men living with HIV (2003) Reprod Health Matters, 11 (22), pp. 91-100 Matida, L.H., Marcopito, L.F., Succi, R.C., Marques, H.H., Della Negra, M., Grangeiro, A., Improving survival among Brazilian children with perinatally-acquired AIDS (2004) Braz J Infect Dis, 8 (6), pp. 419-423 Dunn, D.T., Newell, M.L., Ades, A.E., Peckham, C.S., Risk of human immunodeficiency virus type 1 transmission through breast feeding (1992) Lancet, 340 (8819), pp. 585-588 Fletcher, R., Fletcher, S., (2006) Clinical epidemiology: The essentials, , 4th ed. Lippincott: Williams & Wilkins; Is zidovudine therapy in pregnant HIV-infected women associated with gestational age and birthweight? The European Collaborative Study. AIDS. 1999;13(1):119-24Matida, L.M., da Silva, M.H., Tayra, A., Sued, R.C., Gianna, M.C., Gonçalves, A., Prevention of mother-to-child transmission of HIV in São Paulo state, Brazil: An update (2005) AIDS, 19 (SUPPL. 4), pp. S37-S41 Mussi-Pinhata, M.M., Kato, C.M., Duarte, G., Paschoini, M.C., Bettiol, H., Quintana, S.M., Factors associated with vertical HIV transmission during two different time periods: The impact of zidovudine use on clinical practice at a Brazilian reference center (2003) Int J STD AIDS, 14 (12), pp. 818-825 Wade, N.A., Birkhead, G.S., Warren, B.L., Charbonneau, T.T., French, T., Wang, L., Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus (1998) N Engl J Med, 339 (2), pp. 1409-1414 Lorenzi, P., Spicher, V.M., Laubereau, B., Hirschel, B., Kind, C., Rudin, C., Antiretroviral therapies in pregnancy: Maternal, fetal and neonatal effects. Swiss HIV Cohort Study, The Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study (1998) AIDS, 12 (18), pp. F241-F247 McGowan, J.P., Crane, M., Wiznia, A.A., Blum, S., Combination antiretroviral therapy in human immunodeficiency virus-infected pregnant women (1999) Obstet Gynecol, 94 (5 PART 1), pp. 641-646 Nogueira, S.A., Abreu, T., Oliveira, R., Araujo, L., Costa, T., Andrade, M., Successful prevention of HIV transmission from mother to infant in Brazil using a multidisciplinary team approach (2001) Braz J Infect Dis, 5 (2), pp. 78-86 Kreitchmann, R., Fuchs, S.C., Suffert, T., Preussler, G., Perinatal HIV-1 transmission among low income women participants in the HIV/AIDS Control Program in Southern Brazil: A cohort study (2004) BJOG, 111 (6), pp. 579-584 Mandelbrot, L., Le Chenadec, J., Berrebi, A., Bongain, A., Benifla, J.L., Delfraissy, J.F., Perinatal HIV-1 transmission: Interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort (1998) JAMA, 280 (1), pp. 55-60 Grosch-Wömer, I., Schäfer, A., Oblanden, M., Maier, R.F., Seel, K., Feiterna-Sperling, C., An effective and safe protocol involving zidovudine and cesarean section to reduce vertical transmission of HIV-1 infection (2000) AIDS, 14 (18), pp. 2903-2911 a randomized clinical trial. The European Mode Of Delivery Collaboration (1999) Lancet, 353 (9158), pp. 1035-1039. , Elective cesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission Swiss Mother and Child HIV Cohort Study. Combination antiretroviral therapy and duration of pregnancy (2000) AIDS, 14 (18), pp. 2913-2920. , The European Collaborative Study;